Naeha Gupta, DO
Dermatology · Philadelphia, PANPI 1588028799
Payments from drug & device makers
Across 442 payments — averaging $238.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$29K
- LEO Pharma Inc.$27K
- Incyte Corporation$23K
- Galderma Laboratories, L.p.$16K
- Johnson & Johnson$7K
- AbbVie$691
- plus $4K from 31 others
What the payments were for
- Consulting fees$11,21611%
- Speaking & faculty fees$74,34671%
- Travel & lodging$7,5427%
- Food & beverage$12,10511%
- Education$1670%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 54 | $28,920 |
| LEO Pharma Inc. | 57 | $27,021 |
| Incyte Corporation | 58 | $22,834 |
| Galderma Laboratories, L.p. | 31 | $15,560 |
| Johnson & Johnson | 46 | $6,578 |
| AbbVie | 38 | $691 |
| Amgen | 10 | $596 |
| Dermavant Sciences, Inc. | 27 | $591 |
| Mayne Pharma Commercial LLC | 25 | $451 |
| Organon | 13 | $347 |
| Sanofi | 13 | $253 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 10 | $243 |
| Regeneron Healthcare Solutions, Inc. | 7 | $202 |
| Lilly USA, LLC | 3 | $107 |
| Bristol Myers Squibb | 5 | $105 |
| Gilead | 5 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
| Arcutis Biotherapeutics, Inc. | 5 | $91 |
| Sanofi-aventis U.S. LLC | 2 | $87 |
| Novartis | 5 | $82 |
| Botanix SB Inc | 3 | $56 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Janssen Scientific Affairs, LLC | 2 | $33 |
| Banner Life Sciences, LLC | 1 | $32 |
| Pfizer | 2 | $29 |
| Grifols USA, LLC | 1 | $28 |
| Neos Therapeutics, LP | 2 | $25 |
| Exact Sciences | 1 | $22 |
| Kaleo, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Corium, LLC | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Journey Medical Corporation | 1 | $14 |
| Almirall LLC | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$105,377 in reported general payments places this provider in the 90th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 22 | $291 |
| Triamcinolone Acetonide | 14 | $114 |
| Hydrocortisone | 15 | $73 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Philadelphia
- Victoria WerthPhiladelphia$7.2M
- Joel GelfandPhiladelphia$3.6M
- Lawrence ParishPhiladelphia$2.9M
- Stephen HessPhiladelphia$1.7M
- Susan TaylorPhiladelphia$939K
- Jennifer ParishPhiladelphia$926K
- Nicholas MollanazarPhiladelphia$509K
- Zelma Chiesa FuxenchPhiladelphia$396K
- Katrina AbuabaraPhiladelphia$359K
- Joy WanPhiladelphia$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.